We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Clarifies When PMA Supplement Needed
Guidance Clarifies When PMA Supplement Needed
January 13, 2009
The U.S. Food and Drug Administration (FDA) is recommending that devicemakers carefully assess which submission they need to file when they change manufacturing procedures for a product — either filing a 30-day notice or a special premarket approval (PMA) supplement.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor